The TAE score predicts prognosis of unresectable HCC patients treated with TACE plus lenvatinib with PD-1 inhibitors.

Zhen-Xin ZengJia-Yi WuJun-Yi WuYi-Nan LiYang-Kai FuZhi-Bo ZhangDe-Yi LiuHan LiXiang-Ye OuShao-Wu ZhuangMao-Lin Yan

Published in: Hepatology international (2023)

Triple therapy showed encouraging clinical outcomes, and the TAE score aids in identifying patients who would benefit the most from triple therapy.

Keyphrases